ACAD: ACADIA Corp PEG multiplikatori
ACADIA Pharmaceuticals (ACAD) kompaniyasining malakali boshqaruvi klinik sinovlarda shaffoflikni va patentlarning samarali himoyasini ta'minlaydi. GURU.Markets tizimi peg darajasi dinamikasini taqdim etadi, bunda joriy daraja taxminan 0.00 ni tashkil etadi. Parkinson kasalligining noyob dori vositalari uchun premium narxlar yuqori marjalarni kafolatlaydi. Biznes barqarorligi AQSH dagi ichki ishlab chiqarish va tor neurobiologik nishalardagi kuchli yetakchilik bilan qo'llab-quvvatlanadi.
ACADIA Pharmaceuticals (ACAD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati acadia-pharm.com|ACAD - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati ACADIA Pharmaceuticals Inc|ACAD - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari ACADIA Pharmaceuticals|Tezkor likvidlik koeffitsiyenti acadia-pharm.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ACAD - Kompaniyaning sof foydasi|Kutilayotgan sof daromad ACADIA Pharmaceuticals|ACAD - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ACADIA Corp|ACAD - PEG multiplikatori|EV/EBITDA multiplikatori ACADIA Pharmaceuticals Inc|ACAD - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda ACADIA Pharmaceuticals|ACAD - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi acadia-pharm.com|ACAD - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi ACADIA Pharmaceuticals
Kompaniyaning fundamental tahlili:ACADIA Pharma - ACAD
ACADIA Pharmaceuticals (ACAD) nevrologik dori-darmonlar ta'minot zanjirlarining ishonchliligi normallashtirilgan PEG koeffitsiyentini tahlil qilish uchun barqaror asos yaratadi. 0.00 ning joriy qiymati foyda o'sish sur'atlariga nisbatan P/E koeffitsiyentini aks ettiradi, bunda birdan past ko'rsatkich biznesning kengayishiga nisbatan past baholanganligini anglatadi va bu moliyaviy risklar nazorat qilingan taqdirda investorlarga aktivning o'sish potentsialini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
Narx-foyda va o‘sish multiplikatori Biogen Inc BIIB|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|PEG multiplikatori Regencell Corp RGC|Axsome Therapeutics - PEG multiplikatori|XENE (xenon-pharma.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VKTX: PEG multiplikatori|SUPN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CPRX (Catalyst Pharmaceuticals Inc) - PEG multiplikatori|PEG multiplikatori Denali Corp|Narx-foyda va o‘sish multiplikatori HRMY (Harmony Biosciences)|BHVN (biohavenpharma.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Amylyx Pharmaceuticals, Inc. AMLX|TRVI (Trevi Therapeutics Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Praxis Medicines - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CBLL: PEG multiplikatori|Prothena (PRTA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alector Inc.|ANNX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Omeros Corporation (OMER)|Narx-foyda va o‘sish multiplikatori Neurogene Therapeutics NGNE|PEG multiplikatori ACIU (AC Immune)|PEG multiplikatori voyagertherapeutics.com VYGR|Neumora Therapeutics, Inc. - PEG multiplikatori|Scilex Holding (SCLX) - Narx-foyda va o‘sish multiplikatori|TVGN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alpha Cognition Inc. (ACOG)|Narx-foyda va o‘sish multiplikatori CGTX|PEG multiplikatori inhibikase.com|Narx-foyda va o‘sish multiplikatori SAVA (Cassava Sciences)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ASRT|PEG multiplikatori COYA (Coya Therapeutics)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati VistaGen Therapeutics, Inc. (VTGN)|Ovid Rx - PEG multiplikatori|acumenpharm.com (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO: PEG multiplikatori|Alterity Therapeutics Limited (ATHE) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|Narxning foydaga va o‘sish sur’atiga nisbati PEPG|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|PEG multiplikatori ANVS (Annovis Bio)|PEG multiplikatori Grace Therapeutics Inc GRCE|Firefly Neuroscience Inc - PEG multiplikatori|Klotho Neurosciences Inc (KLTO) - Narx-foyda va o‘sish multiplikatori|NRSN: PEG multiplikatori|revivapharma.com (RVPH) - PEG multiplikatori|MTVA (MetaVia Inc.) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NRXS (NeurAxis Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|PEG multiplikatori BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA - Narx-foyda va o‘sish multiplikatori|Chromocell Therapeutics - PEG multiplikatori|ELYM - PEG multiplikatori|ITCI: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|MRNS (Marinus) - PEG multiplikatori|NKGen Biotech Corp (NKGN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori NRBO|PEG multiplikatori sagerx.com (SAGE)|Synaptogenix - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori
